(ASCN) Ascom Holding - Ratings and Ratios

Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0011339204

ASCN: Nurse Call Systems, Workflow Software, Mobile Devices, Consulting Services

Ascom Holding AG (SW:ASCN) is a global provider of healthcare ICT and mobile workflow solutions, enabling seamless communication and coordination in clinical environments. The companys product portfolio includes advanced nurse call systems such as teleCARE IP, which offers wireless communication, alerts, and wander management, and Telligence, a patient response system designed to optimize care delivery. Its Digistat suite provides clinical workflow software, while Unite software serves as a workflow orchestration platform, integrating data from diverse systems and enabling task management across multiple devices. Additionally, Ascom offers mobile devices including smartphones, DECT and VoWiFi phones, and pagers, ensuring reliable communication in healthcare settings. The company also provides consulting, implementation, training, and support services to ensure optimal system integration and operation. Established in 1996 and headquartered in Baar, Switzerland, Ascom has become a key player in healthcare technology, focusing on improving patient outcomes through innovative communication solutions.

Based on the provided data, Ascom Holding AG (SW:ASCN) is expected to maintain its position in the healthcare ICT sector over the next three months. The stocks technical indicators, such as the SMA ratios (20: 3.67, 50: 3.76, 200: 5.38) and average volume of 154,320 shares, suggest moderate trading activity with potential price stability near the current level of 3.60 CHF. The ATR of 0.15 indicates relatively low volatility, which may limit significant price swings in the short term. On the fundamental side, the companys market cap of 136.12M CHF, P/E ratio of 9.02, and ROE of 27.62% reflect a stable financial position with efficient returns on equity. The forward P/E of 14.10 suggests expectations of future earnings growth, which could support the stock price. Overall, Ascom is likely to experience steady performance, supported by its established market presence and focus on healthcare communication solutions.

Additional Sources for ASCN Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

ASCN Stock Overview

Market Cap in USD 151m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Technology
IPO / Inception

ASCN Stock Ratings

Growth 5y -44.7%
Fundamental 68.3%
Dividend 63.2%
Rel. Strength Industry -51.1
Analysts -
Fair Price Momentum 3.20 CHF
Fair Price DCF 16.15 CHF

ASCN Dividends

Dividend Yield 12m 6.50%
Yield on Cost 5y 6.54%
Annual Growth 5y 14.47%
Payout Consistency 47.4%

ASCN Growth Ratios

Growth Correlation 3m -49.1%
Growth Correlation 12m -93.9%
Growth Correlation 5y -55.2%
CAGR 5y -3.98%
CAGR/Max DD 5y -0.05
Sharpe Ratio 12m -1.00
Alpha -55.07
Beta 0.10
Volatility 37.03%
Current Volume 88.1k
Average Volume 20d 89.6k
What is the price of ASCN stocks?
As of March 15, 2025, the stock is trading at CHF 3.75 with a total of 88,052 shares traded.
Over the past week, the price has changed by -2.47%, over one month by +0.13%, over three months by -7.76% and over the past year by -50.67%.
Is Ascom Holding a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Ascom Holding (SW:ASCN) is currently (March 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 68.28 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ASCN as of March 2025 is 3.20. This means that ASCN is currently overvalued and has a potential downside of -14.67%.
Is ASCN a buy, sell or hold?
Ascom Holding has no consensus analysts rating.
What are the forecast for ASCN stock price target?
According to ValueRays Forecast Model, ASCN Ascom Holding will be worth about 3.5 in March 2026. The stock is currently trading at 3.75. This means that the stock has a potential downside of -7.47%.
Issuer Forecast Upside
Wallstreet Target Price 5.2 39.5%
Analysts Target Price - -
ValueRay Target Price 3.5 -7.5%